26.08.2017 04:50:00

PetMED INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates PetMed Express, Inc. for Possible Securities Fraud - (PETS)

NEW ORLEANS, Aug. 25, 2017 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into PetMed Express, Inc. (NASDAQ: PETS).

Kahn Swick & Foti, LLC (

On August 23, 2017, it was revealed through a report issued by Aurelius Value that PetMed Express had targeted its products to opioid users through the use of Google ads and other marketing practices to potentially facilitate the abuse of opiates.

On this news, the price of PetMed's shares plummeted. 

KSF's investigation is focusing on whether PetMed and/or its officers and directors violated state or federal securities laws. 

If you are a PetMed shareholder and have suffered losses, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit http://ksfcounsel.com/cases/petmed-express-inc-nasdaq-pets-investigation  to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include the former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
206 Covington St.
Madisonville, LA 70447

 

View original content with multimedia:http://www.prnewswire.com/news-releases/petmed-investigation-initiated-by-former-louisiana-attorney-general-kahn-swick--foti-llc-investigates-petmed-express-inc-for-possible-securities-fraud---pets-300509850.html

SOURCE Kahn Swick & Foti, LLC

Analysen zu PetMed Express Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

PetMed Express Inc. 5,25 -0,23% PetMed Express Inc.